Verily, a company specializing in precision medicine powered by artificial intelligence, has entered into a strategic collaboration with NVIDIA. Under the agreement, Verily’s Pre platform will be equipped with NVIDIA’s full technology stack — from GPU-accelerated computing (including the Blackwell and Hopper architectures) to software libraries such as NeMo, Parabricks, and CUDA-X Data Science. This integration is expected to reduce analysis times from several hours to just minutes, a breakthrough particularly significant in the fields of genomics and high-dimensional health data.
The collaboration will primarily focus on the All of Us Researcher Workbench — a research environment involving around 20,000 registered scientists worldwide, hosting one of the largest genomic and clinical databases in existence. On the Pre platform, Verily and Vanderbilt University Medical Center will use NVIDIA’s capabilities to accelerate the development of multimodal models combining EHR (electronic health records) with genomic data.
But that’s not all — the expansion of the Pre platform will also introduce two additional modules: Refinery – a creator engine for unifying multimodal data using an FHIR-native model, and Exchange – a secure environment for sharing curated datasets, models, and AI agents for research and clinical care.
Although it remains to be seen how effective the partnership will be and what tangible outcomes it will yield, the combination of NVIDIA’s advanced technology and Verily’s robust healthcare platform looks extremely promising. Potential benefits include accelerated research and the creation of more accurate disease prediction models — achievements that would be nearly impossible without the proper technological foundation.
The close collaboration also means Verily won’t just be a client using NVIDIA’s tools — thanks to this partnership, it will gain access to customized, co-developed solutions tailored to its specific needs.